CytoCore announces its Third International Distribution Agreement

Exhibit 99.1

Press Release		Source: CytoCore, Inc.

CytoCore announces its Third International Distribution Agreement

Tuesday, November 13, 9:30 am ET

CytoCore signs Agreement with Grupo Palex SA for distribution in Spain

CHICAGO—(BUSINESS WIRE)—CytoCore, Inc. (OTCBB: CYCR — News ) , a biopharmaceutical research and medical device company focused on early detection and treatment of reproductive-tract cancers, today announced that it has entered into a five year agreement with three-one year “evergreen” extensions with Grupo Palex SA for distribution of the SoftPap Cervical Cell Collector into Spain. Palex is one of Europe’s leading distributors of medical products and services to hospitals. Palex’s agreement calls for minimum sales of 600K units the first year, 1.2mm units the second, 2.4mm units minimum the third year, with 10% increases each year thereafter.

CytoCore CEO Robert McCullough Jr. stated “Palex is recognized as a leader in bringing new medical technology to their markets. We are very excited with this agreement and the opportunity to partner with Palex as we enter the European markets. Palex has expertise in the diagnostic market and they have expressed an interest in helping us develop and expand the Automated Image-Guided Proteomic System (AIPS) platform. The AIPS system provides the cytologist with computerized assistance in the evaluation and review of conventionally and fluorescently stained cytology specimens. CytoCore is developing and testing fluorescent Uterine and Cervical cancer screening assays to work with the AIPS platform.”

“Dr. Augusto Ocana who helped build CH-Werfen to a billion dollar European medical products company has b